Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE27.7000
- TODAY'S CHANGE (%)-0.4200 (-1.4936%)
- Bid / Lots27.5000/ 3
- Ask / Lots28.9200/ 7
- Open / Previous Close28.0400 / 28.1200
- Day Range
- 52 Week Range
- Volume1,620,825
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 8815 | 28 |
| 09:34 ET | 600 | 27.92 |
| 09:36 ET | 1177 | 27.915 |
| 09:38 ET | 1253 | 28 |
| 09:39 ET | 2074 | 28.02 |
| 09:41 ET | 3861 | 28.015 |
| 09:43 ET | 984 | 27.97 |
| 09:45 ET | 1400 | 28.01 |
| 09:48 ET | 7203 | 28.06 |
| 09:50 ET | 3640 | 28.06 |
| 09:52 ET | 109905 | 28.09 |
| 09:54 ET | 1921 | 27.99 |
| 09:56 ET | 1567 | 27.99 |
| 09:57 ET | 394 | 27.99 |
| 09:59 ET | 100 | 27.99 |
| 10:01 ET | 2351 | 27.94 |
| 10:03 ET | 5101 | 27.92 |
| 10:06 ET | 2377 | 27.93 |
| 10:08 ET | 2372 | 27.94 |
| 10:10 ET | 2600 | 27.93 |
| 10:12 ET | 5386 | 27.9798 |
| 10:14 ET | 2700 | 27.965 |
| 10:15 ET | 4946 | 27.965 |
| 10:17 ET | 2719 | 27.97 |
| 10:19 ET | 1700 | 27.96 |
| 10:21 ET | 1003 | 27.985 |
| 10:24 ET | 1421 | 27.985 |
| 10:26 ET | 1528 | 27.96 |
| 10:28 ET | 1000 | 27.965 |
| 10:30 ET | 7842 | 27.945 |
| 10:32 ET | 3499 | 27.945 |
| 10:33 ET | 1050 | 27.94 |
| 10:35 ET | 1466 | 27.935 |
| 10:37 ET | 2894 | 27.94 |
| 10:39 ET | 2044 | 27.905 |
| 10:42 ET | 2141 | 27.93 |
| 10:44 ET | 1737 | 27.95 |
| 10:46 ET | 10628 | 27.985 |
| 10:48 ET | 11310 | 28 |
| 10:50 ET | 3300 | 28 |
| 10:51 ET | 1479 | 27.99 |
| 10:53 ET | 1000 | 27.99 |
| 10:55 ET | 15440 | 28.005 |
| 10:57 ET | 4821 | 28.005 |
| 11:00 ET | 3503 | 28.05 |
| 11:02 ET | 2081 | 28.025 |
| 11:04 ET | 641 | 28.01 |
| 11:06 ET | 1693 | 28.02 |
| 11:08 ET | 7859 | 28.025 |
| 11:09 ET | 1897 | 28.005 |
| 11:11 ET | 4991 | 27.965 |
| 11:13 ET | 700 | 27.955 |
| 11:15 ET | 1400 | 27.95 |
| 11:18 ET | 1000 | 27.975 |
| 11:20 ET | 600 | 27.965 |
| 11:22 ET | 300 | 27.965 |
| 11:24 ET | 1253 | 27.97 |
| 11:26 ET | 401 | 27.985 |
| 11:27 ET | 405 | 27.9808 |
| 11:29 ET | 3979 | 27.995 |
| 11:31 ET | 4615 | 27.975 |
| 11:33 ET | 6069 | 27.975 |
| 11:36 ET | 13691 | 27.965 |
| 11:38 ET | 1600 | 27.975 |
| 11:40 ET | 972 | 27.965 |
| 11:42 ET | 5175 | 27.965 |
| 11:44 ET | 2765 | 27.965 |
| 11:45 ET | 2681 | 27.995 |
| 11:47 ET | 486 | 27.9986 |
| 11:49 ET | 1000 | 28.015 |
| 11:51 ET | 2216 | 27.995 |
| 11:54 ET | 2457 | 27.985 |
| 11:56 ET | 700 | 27.985 |
| 11:58 ET | 11761 | 28 |
| 12:00 ET | 2125 | 28.005 |
| 12:02 ET | 2997 | 27.96 |
| 12:03 ET | 1000 | 27.985 |
| 12:05 ET | 100 | 27.985 |
| 12:07 ET | 1029 | 27.98 |
| 12:09 ET | 900 | 28 |
| 12:12 ET | 2203 | 27.995 |
| 12:14 ET | 400 | 27.995 |
| 12:16 ET | 4142 | 27.99 |
| 12:18 ET | 522 | 27.995 |
| 12:20 ET | 3413 | 28.015 |
| 12:21 ET | 5246 | 28.015 |
| 12:23 ET | 1000 | 28.015 |
| 12:25 ET | 1816 | 28.015 |
| 12:27 ET | 626 | 28.02 |
| 12:30 ET | 3811 | 28.005 |
| 12:32 ET | 1667 | 28.015 |
| 12:34 ET | 1806 | 28.005 |
| 12:36 ET | 6031 | 27.9647 |
| 12:38 ET | 3507 | 27.965 |
| 12:39 ET | 5579 | 27.95 |
| 12:41 ET | 5186 | 27.9499 |
| 12:43 ET | 1131 | 27.945 |
| 12:45 ET | 4802 | 27.92 |
| 12:48 ET | 1332 | 27.95 |
| 12:50 ET | 3355 | 27.975 |
| 12:52 ET | 2662 | 27.97 |
| 12:54 ET | 100 | 27.965 |
| 12:56 ET | 1871 | 27.96 |
| 12:57 ET | 7132 | 27.945 |
| 12:59 ET | 751 | 27.935 |
| 01:01 ET | 1263 | 27.93 |
| 01:03 ET | 2240 | 27.935 |
| 01:06 ET | 3167 | 27.935 |
| 01:08 ET | 7608 | 27.945 |
| 01:10 ET | 4622 | 27.935 |
| 01:12 ET | 1696 | 27.9311 |
| 01:14 ET | 1700 | 27.93 |
| 01:15 ET | 2400 | 27.915 |
| 01:17 ET | 38766 | 27.91 |
| 01:19 ET | 31321 | 27.89 |
| 01:21 ET | 400 | 27.91 |
| 01:24 ET | 200 | 27.905 |
| 01:26 ET | 1592 | 27.9 |
| 01:28 ET | 654 | 27.905 |
| 01:30 ET | 2625 | 27.885 |
| 01:32 ET | 1800 | 27.885 |
| 01:33 ET | 887 | 27.87 |
| 01:35 ET | 700 | 27.86 |
| 01:37 ET | 1978 | 27.85 |
| 01:39 ET | 484 | 27.855 |
| 01:42 ET | 2381 | 27.84 |
| 01:44 ET | 1241 | 27.855 |
| 01:46 ET | 1808 | 27.86 |
| 01:48 ET | 500 | 27.875 |
| 01:50 ET | 2000 | 27.885 |
| 01:51 ET | 1584 | 27.8811 |
| 01:53 ET | 400 | 27.89 |
| 01:55 ET | 1665 | 27.895 |
| 01:57 ET | 1900 | 27.91 |
| 02:00 ET | 2410 | 27.915 |
| 02:02 ET | 1637 | 27.9167 |
| 02:04 ET | 540 | 27.92 |
| 02:06 ET | 2971 | 27.915 |
| 02:08 ET | 1849 | 27.895 |
| 02:11 ET | 1968 | 27.87 |
| 02:13 ET | 4814 | 27.875 |
| 02:15 ET | 844 | 27.865 |
| 02:18 ET | 1443 | 27.865 |
| 02:20 ET | 200 | 27.865 |
| 02:22 ET | 500 | 27.865 |
| 02:24 ET | 4215 | 27.85 |
| 02:26 ET | 803 | 27.855 |
| 02:27 ET | 4375 | 27.8277 |
| 02:29 ET | 1261 | 27.83 |
| 02:31 ET | 1963 | 27.85 |
| 02:33 ET | 3723 | 27.835 |
| 02:36 ET | 1125 | 27.845 |
| 02:38 ET | 5058 | 27.83 |
| 02:40 ET | 969 | 27.83 |
| 02:42 ET | 702 | 27.825 |
| 02:44 ET | 3044 | 27.82 |
| 02:45 ET | 2782 | 27.815 |
| 02:47 ET | 1400 | 27.815 |
| 02:49 ET | 2304 | 27.815 |
| 02:51 ET | 2781 | 27.8012 |
| 02:54 ET | 300 | 27.805 |
| 02:56 ET | 875 | 27.805 |
| 02:58 ET | 1629 | 27.82 |
| 03:00 ET | 2292 | 27.83 |
| 03:02 ET | 2761 | 27.835 |
| 03:03 ET | 900 | 27.845 |
| 03:05 ET | 2553 | 27.83 |
| 03:07 ET | 2282 | 27.825 |
| 03:09 ET | 300 | 27.815 |
| 03:12 ET | 585 | 27.82 |
| 03:14 ET | 3627 | 27.82 |
| 03:16 ET | 2847 | 27.795 |
| 03:18 ET | 3086 | 27.785 |
| 03:20 ET | 4727 | 27.785 |
| 03:21 ET | 1031 | 27.785 |
| 03:23 ET | 2568 | 27.785 |
| 03:25 ET | 6763 | 27.795 |
| 03:27 ET | 3374 | 27.8 |
| 03:30 ET | 5200 | 27.79 |
| 03:32 ET | 3186 | 27.79 |
| 03:34 ET | 4116 | 27.785 |
| 03:36 ET | 3048 | 27.775 |
| 03:38 ET | 7682 | 27.755 |
| 03:39 ET | 5309 | 27.735 |
| 03:41 ET | 7569 | 27.73 |
| 03:43 ET | 8799 | 27.725 |
| 03:45 ET | 7515 | 27.721 |
| 03:48 ET | 12205 | 27.735 |
| 03:50 ET | 5361 | 27.795 |
| 03:52 ET | 12233 | 27.755 |
| 03:54 ET | 16343 | 27.745 |
| 03:56 ET | 33246 | 27.78 |
| 03:57 ET | 26333 | 27.755 |
| 03:59 ET | 69501 | 27.7 |
Apr 19, 2024
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024, from 8:15AM ET on Friday Apr 19, 2024 by Dow Jones
8:15AM ET on Friday Apr 19, 2024 by Dow Jones
Apr 17, 2024
Royalty Pharma Declares Second Quarter 2024 Dividend, from 8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:15AM ET on Wednesday Apr 17, 2024 by Dow JonesPress Release: Royalty Pharma Declares Second Quarter 2024 Dividend, from 8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
Apr 12, 2024
DJ Royalty Pharma Is Maintained at Buy by B of A Securities, from 8:11AM ET on Friday Apr 12, 2024 by Dow Jones
8:11AM ET on Friday Apr 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 16.8B | 10.9x | +1.83% |
Amneal Pharmaceuticals Inc | 1.8B | -19.4x | --- |
Catalent Inc | 10.2B | -7.8x | --- |
Jazz Pharmaceuticals PLC | 6.9B | 18.1x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.6B | -43.7x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Research and Investments
- Marshall Urist
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.8B |
|---|---|
Revenue (TTM) | $2.4B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.03% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.46 |
EPS | $2.54 |
Book Value | $14.61 |
P/E Ratio | 10.9x |
Price/Sales (TTM) | 7.1 |
Price/Cash Flow (TTM) | 9.9x |
Operating Margin | 63.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
